Marchetti, M.; Ferrari, J.; Vezzaro, T.; Masatti, L.; Tasca, G.; Maggino, T.; Tozzi, R.; Saccardi, C.; Noventa, M.; Spagnol, G.
The Role of Immunotherapy in MMR-Deficient Endometrial Carcinoma: State of the Art and Future Perspectives. J. Clin. Med. 2024, 13, 7041.
https://doi.org/10.3390/jcm13237041
AMA Style
Marchetti M, Ferrari J, Vezzaro T, Masatti L, Tasca G, Maggino T, Tozzi R, Saccardi C, Noventa M, Spagnol G.
The Role of Immunotherapy in MMR-Deficient Endometrial Carcinoma: State of the Art and Future Perspectives. Journal of Clinical Medicine. 2024; 13(23):7041.
https://doi.org/10.3390/jcm13237041
Chicago/Turabian Style
Marchetti, Matteo, Jacopo Ferrari, Tommaso Vezzaro, Laura Masatti, Giulia Tasca, Tiziano Maggino, Roberto Tozzi, Carlo Saccardi, Marco Noventa, and Giulia Spagnol.
2024. "The Role of Immunotherapy in MMR-Deficient Endometrial Carcinoma: State of the Art and Future Perspectives" Journal of Clinical Medicine 13, no. 23: 7041.
https://doi.org/10.3390/jcm13237041
APA Style
Marchetti, M., Ferrari, J., Vezzaro, T., Masatti, L., Tasca, G., Maggino, T., Tozzi, R., Saccardi, C., Noventa, M., & Spagnol, G.
(2024). The Role of Immunotherapy in MMR-Deficient Endometrial Carcinoma: State of the Art and Future Perspectives. Journal of Clinical Medicine, 13(23), 7041.
https://doi.org/10.3390/jcm13237041
